Association of a Device-Based Remote Management Heart Failure Pathway with Outcomes: TriageHF Plus Real-World Evaluation
ESC Heart Failure · 01.10.2024 · 11 (5) · 2637-2647
DOI: 10.1002/ehf2.14821 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift ESC Heart Failure, online erschienen am 07.05.2024. Verfasst von Fozia Zahir Ahmed und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Manchester University Hospitals NHS Foundation Trust, Manchester, UK. Hauptthemen laut MEDLINE: COVID-19, Heart Failure. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Medtronic, National Institute for Health and Care Research Applied Research Collaboration Greater Manchester, British Heart Foundation.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Aims
Clinical pathways have been shown to improve outcomes in patients with heart failure (HF). Although patients with HF often have a cardiac implantable electronic device, few studies have reported the utility of device-derived risk scores to augment and organize care. TriageHF Plus is a device-based HF clinical pathway (DHFP) that uses remote monitoring alerts to trigger structured telephone assessment for HF stability and optimization. We aimed to evaluate the impact of TriageHF Plus on hospitalizations and describe the associated workforce burden. Methods and results TriageHF Plus was a multi-site, prospective study that compared outcomes for patients recruited between April 2019 and February 2021. All alert-triggered assessments were analysed to determine the appropriateness of the alert and the workload burden. A negative-binomial regression with inverse probability treatment weighting using a time-matched usual care cohort was applied to estimate the effect of TriageHF Plus on non-elective hospitalizations. A post hoc pre-COVID-19 sensitivity analysis was also performed. The TriageHF Plus cohort (n = 443) had a mean age of 68.8 ± 11.2 years, 77% male (usual care cohort: n = 315, mean age of 66.2 ± 14.5 years, 65% male). In the TriageHF Plus cohort, an acute medical issue was identified following an alert in 79/182 (43%) cases. Fifty assessments indicated acute HF, requiring clinical action in 44 cases. At 30 day follow-up, 39/66 (59%) of initially symptomatic patients reported improvement, and 20 (19%) initially asymptomatic patients had developed new symptoms. On average, each assessment took 10 min. The TriageHF Plus group had a 58% lower rate of hospitalizations across full follow-up [incidence relative ratio: 0.42, 95% confidence interval (CI): 0.23–0.76, P = 0.004]. Across the pre-COVID-19 window, hospitalizations were 31% lower (0.69, 95% CI: 0.46–1.04, P = 0.077).
Conclusions
These data represent the largest real-world evaluation of a DHFP based on multi-parametric risk stratification. The TriageHF Plus clinical pathway was associated with an improvement in HF symptoms and reduced all-cause hospitalizations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cardiology, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
- Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.
- Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester Academic Health Science Centre, Manchester, UK.
- Liverpool Heart and Chest Hospital NHS Foundation Trust, Liverpool, UK.
- Department of Cardiology, Northern Care Alliance NHS Foundation Trust, Manchester, UK.
- Statistics Department, Research and Innovation, Manchester University NHS Foundation Trust, Manchester, UK.
Förderung
- Medtronic
- National Institute for Health and Care Research Applied Research Collaboration Greater Manchester
- British Heart Foundation
- Collaboration for Leadership in Applied Health Research and Care - Greater Manchester
Zitieren
APA
Ahmed, F. Z., Sammut-Powell, C., Martin, G. P., Callan, P., Cunnington, C., Kahn, M., Kale, M., Weldon, T., Harwood, R., Fullwood, C., Gerritse, B., Lanctin, D., Soken, N., Campbell, N. G., & Taylor, J. K. (2024). Association of a Device-Based Remote Management Heart Failure Pathway with Outcomes: TriageHF Plus Real-World Evaluation. ESC Heart Failure, 11(5), 2637-2647. https://doi.org/10.1002/ehf2.14821
Vancouver
Ahmed FZ, Sammut-Powell C, Martin GP, Callan P, Cunnington C, Kahn M, et al. Association of a Device-Based Remote Management Heart Failure Pathway with Outcomes: TriageHF Plus Real-World Evaluation. ESC Heart Failure. 2024;11(5):2637-2647. doi:10.1002/ehf2.14821
BibTeX
@article{Ahmed2024,
author = {Ahmed, Fozia Zahir and Sammut-Powell, Camilla and Martin, Glen P and Callan, Paul and Cunnington, Colin and Kahn, Matthew and Kale, Mita and Weldon, Toni and Harwood, Rachel and Fullwood, Catherine and Gerritse, Bart and Lanctin, David and Soken, Nelson and Campbell, Niall G and Taylor, Joanne K},
title = {Association of a Device-Based Remote Management Heart Failure Pathway with Outcomes: TriageHF Plus Real-World Evaluation},
journal = {ESC Heart Failure},
year = {2024},
volume = {11},
number = {5},
pages = {2637--2647},
doi = {10.1002/ehf2.14821}
}
EUVIMED